期刊
REJUVENATION RESEARCH
卷 13, 期 2-3, 页码 327-328出版社
MARY ANN LIEBERT INC
DOI: 10.1089/rej.2009.0966
关键词
-
Recent policy developments in the United States and Europe have created new regulatory regimes for advanced and complex treatments such as cell therapies, tissue engineering, and gene therapies that are of particular relevance for regenerative medicine. Where these new legal rules operate as a mere extension of existing regimes, they risk stifling innovation in these areas of life extension technology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据